13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.
Gifu University
Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
University of Montpellier
Activation of human RNase L by 2'- and 5'-O-methylphosphonate-modified oligoadenylates.
Academy of Sciences of The Czech Republic
Small-molecule activators of RNase L with broad-spectrum antiviral activity.
Lerner Research Institute
Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
Gunma University
Replacement of the ribofuranose oxygen of 2-5A derivatives by methylene: synthesis of an aristeromycin analogue of 2-5A core 5'-monophosphate (5'-O-phosphoryladenylyl)(2'----5')adenyl(2'----5')adenosine.
TBA
5'-O-Dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Gifu University
Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates.
Academy of Sciences of The Czech Republic
Identification of Small Molecule Inhibitors of RNase L by Fragment-Based Drug Discovery.
Peking University Shenzhen Graduate School
Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids.
National Institute of Diabetes and Digestive Antd Kidney Diseases
2-Methyladenosine-Substituted 2',5'-oligoadenylates: conformations, 2-5A binding and catalytic activities with human ribonuclease L.
Gifu University